Winter 2006
Expressions Home

Features

State of the School Address

Art in the Atrium

Who Is This Man?
Leadership Profile

Sharon Dooley, MD, MPH

Staff Member Profiles

New SRC Members Evelyn DiLisio and Jacob Stempky

Q & A

When Will the Food Court Open in the Lurie Research Center?

News

New Finance Head

Chicago Campus Payroll Office

$11.5 Million Facade Repair

Staff Newsmakers

Research Discoveries
Cancer Gene

Adult Depression

Mental Health Services

Primose Oil and Breast Cancer

Health Literacy

Prostate Symptoms

Calendar of Events
Winter Calendar
Links
Past Issues
Credits
Contact Us

Useful Links

Staff Relations Committee (SRC) Web Site

SRC Members

Northwestern Jobs

Medical School Calendar

Viagra Eases Symptoms of Prostate Enlargement

Known for improving erectile dysfunction (ED), Viagra® (sildenafil citrate) also effectively treats the prostate and lower urinary tract symptoms (LUTS) associated with prostate enlargement that often occur with ED, a Northwestern study has found. Professor of urology at the Feinberg School, Kevin McVary, MD, presented clinical trial results at a meeting of the Sexual Medicine Society of North America on November 21 in New York.

Dr. McVary and his colleagues conducted a 12-week, double-blind, placebo-controlled study of Viagra in men aged 45 years and older. Participants had ED and LUTS associated with benign prostatic hyperplasia, an enlargement of the prostate gland that obstructs the flow of urine through the urethra. Study results showed that men who took Viagra (30 minutes to an hour before anticipated sexual activity) experienced a significant improvement in erectile function, self-esteem, and quality of life, with a concomitant decrease in both the irritative and obstructive symptoms of BPH.

More than half of men over 40 years have difficulties getting or maintaining an erection. More than half of men 50 years and older have some sign of BPH. Studies have shown that more than 70 percent of men with symptoms of BPH also have ED. Results from this clinical trial have important implications with respect to the causes of concomitant prostate symptoms and ED, according to researchers.